Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
4,715 results
- A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects: Complete Statistical AnalysisIndependent statistical analysis of A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody: Complete Statistical AnalysisIndependent statistical analysis of A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody: primary endpoint results, effect estimate with confidence…
- A Study for Participants With Small-Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study for Participants With Small-Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01025284).
- A Study for Patients With Non-Hodgkin’s Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of A Study for Patients With Non-Hodgkin's Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00542919).
- A Study for Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of A Study for Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01027871).
- A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients With Stable COPD: Complete Statistical AnalysisIndependent statistical analysis of A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients With Stable COPD: primary endpoint results, effect estimate with confidence…
- A Study in Adults With Untreated Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of A Study in Adults With Untreated Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00136435).
- A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood:…
- A Study in Healthy Men to Compare 2 Different Formulations of Alteplase: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Compare 2 Different Formulations of Alteplase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study in Healthy Men to Test How BI 1265162 is Taken up and Processed by the Body: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test How BI 1265162 is Taken up and Processed by the Body: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study in Healthy Men to Test How Different Doses of BI 474121 Are Taken up and How They Influence the Amount of a Molecular Messenger (cGMP) in the Spinal Fluid: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test How Different Doses of BI 474121 Are Taken up and How They Influence the Amount of a Molecular Messenger (cGMP) in…
- A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121…
- A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body: primary endpoint…
- A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body: primary endpoint results, effect estimate with…
- A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food: primary endpoint results, effect estimate with…
- A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food: primary endpoint results, effect estimate with…
- A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood: primary endpoint results, effect estimate with…
- A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066: Complete Statistical AnalysisIndependent statistical analysis of A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based: Complete Statistical AnalysisIndependent statistical analysis of A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study): Complete Statistical AnalysisIndependent statistical analysis of A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study):…
- A Study in Patients With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of A Study in Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00966875).
- A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication: Complete Statistical AnalysisIndependent statistical analysis of A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of a Single Dose of ALXN1210 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of a Single Dose of ALXN1210 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma: primary endpoint results, effect estimate with confidence interval,…
- A Study of Abemaciclib in Indian Women With Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib in Indian Women With Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body: primary endpoint results, effect estimate with confidence interval,…
- A Study of Abemaciclib in Recurrent Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib in Recurrent Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02981940).
- A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection: Complete Statistical AnalysisIndependent statistical analysis of A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG: Complete Statistical AnalysisIndependent statistical analysis of A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Ad26.COV2.S in Adults (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of A Study of Ad26.COV2.S in Adults (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04436276).
- A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010): Complete Statistical AnalysisIndependent statistical analysis of A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010): primary endpoint results, effect estimate with confidence interval,…
- A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency: Complete Statistical AnalysisIndependent statistical analysis of A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment: Complete Statistical AnalysisIndependent statistical analysis of A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment: primary endpoint results, effect estimate…
- A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects: Complete Statistical AnalysisIndependent statistical analysis of A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002): Complete Statistical AnalysisIndependent statistical analysis of A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014): Complete Statistical AnalysisIndependent statistical analysis of A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart: Complete Statistical AnalysisIndependent statistical analysis of A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had…
- A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19: Complete Statistical AnalysisIndependent statistical analysis of A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission: Complete Statistical AnalysisIndependent statistical analysis of A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission:…